; IMS Health Incorporated (RX) - Financial and Strategic Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

IMS Health Incorporated (RX) - Financial and Strategic Analysis Review

VIEWS: 57 PAGES: 30

IMS Health (IMS) is engaged in providing market intelligence and consulting services to the pharmaceutical and health care industries. IMS is providing the critical business intelligence, including information, analytics and consulting services to the pharmaceutical and health care industries across the globe. It maintains three business lines namely, increasing client's productivity across end-to-end sales, promotional, marketing and performance management processes, clients product and portfolio management and optimization, consulting services for new businesses to support clients initiatives in managed markets, consumer health, pricing and market access. IMS Health Incorporated Key Recent Developments Feb 22, 2010 IMS Introduces Aggregate Compliance Services For Medical Device Companies Feb 18, 2010 R-Squared Enters Into Strategic Partnership With IMS Health Oct 08, 2009 IMS Health Sees Global Pharma Growth At 4-6% In 2010 This comprehensive SWOT profile of IMS Health Incorporated provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competito

More Info
  • pg 1
									        IMS Health Incorporated (RX) - Financial and Strategic Analysis Review

       Reference Code: GDPH30233FSA                                                                                    Publication Date: JUL 2010

       901 Main Avenue                     Phone            +1 203 8455200                        Revenue           2,189.7 (million USD)
       Norwalk, CT                         Fax                                                    Net Profit        258.46 (million USD)
       06851                               Website          www.imshealth.com                     Employees         7,250
       United States                       Exchange         RX [New York Stock Exchange]          Industry          Pharmaceuticals & Healthcare

      Company Overview
       IMS Health (IMS) is engaged in providing market intelligence and consulting services to the pharmaceutical and health care
       industries. IMS is providing the critical business intelligence, including information, analytics and consulting services to the
       pharmaceutical and health care industries across the globe. It maintains three business lines namely, increasing client's
       productivity across end-to-end sales, promotional, marketing and performance management processes, clients product and
       portfolio management and optimization, consulting services for new businesses to support clients initiatives in managed markets,
       consumer health, pricing and market access.

      Key Executives                                                              SWOT Analysis
                     Name                                  Title                  IMS Health Incorporated, SWOT Analysis
       David R. Carlucci                    Chairman                              Strengths                  Weaknesses

       Constantine L. Clemente              Director
                                                                                                                      Highly Leveraged
                                                                                  Strong Market Position
       James D. Edwards                     Director
       Kathryn E. Giusti                    Director                                                                  Declining Market Share in
                                                                                  Extensive range of Services
                                                                                                                      Sector
       H. Eugene Lockhart                   Director
       Source: Annual Report, Company Website, Primary and Secondary Research
       GlobalData
                                                                                  Opportunities                       Threats
      Share Data
       IMS Health Incorporated                                                    Strategic Acquisitions              Technological Advancements
       Share Price (USD) as on 25-Feb-2010                                 22.0
                                                                           1.42   Growing Demand for                  Intellectual Property at Risk
       EPS (USD)
                                                                                  Oncology Market
       Market Cap (million USD)                                          4,027

       Enterprise Value (million USD)                                    4,893

       Shares Outstanding (million)                                        183    Source: Annual Report, Company Website, Primary and Secondary Research
       Source: Annual Report, Company Website, Primary and Secondary Research     GlobalData
       GlobalData

      Financial Performance                                                       Recent Developments
                                                                                  Feb 22, 2010         IMS Intro
								
To top